SPRY experienced a dramatic operational deterioration with operating income plunging from -$3.1M to -$179.4M while market capitalization more than doubled, indicating severe execution challenges during their product commercialization phase.
The company transitioned from near-breakeven operations to massive losses exceeding $170M, suggesting significant commercialization costs and operational scaling issues with their neffy product launch. Despite the financial deterioration, the market value of non-affiliate shares surged from $466M to $1,095M, creating a concerning disconnect between operational performance and market valuation that warrants immediate investor attention.
The financial statements reveal a company in dramatic operational decline, with operating losses expanding by over 5,700% to -$179.4M driven primarily by SG&A expenses tripling to $230M, likely reflecting aggressive commercialization spending. Cash flow turned severely negative at -$170.9M from positive $13.5M, while the balance sheet shows signs of rapid business scaling with inventory up 500% and receivables up 210%, though stockholders' equity was cut in half to $114M. The overall picture suggests a company burning cash at an unsustainable rate during what appears to be a critical product launch phase, with working capital buildups indicating either strong sales growth or concerning inventory accumulation.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Net income declined 2241.8% — review whether driven by operations, interest costs, or non-recurring items.
Operating cash flow fell 1361.2% — earnings quality concerns; investigate working capital changes and non-cash items.
Inventory surged 502.9% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.
SG&A up 221.1% — significant increase in sales or administrative costs, monitor impact on operating leverage.
Receivables surged 210.1% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Liabilities grew 126.2% — significant increase in debt or obligations, assess impact on financial flexibility.
Current liabilities surged 67% — significant near-term obligations; verify ability to meet short-term debt.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Capex reduced 39.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →